Evidence map›Paper›PMID 27104513›Full record

ArticleMolecules (Basel, Switzerland)2016

Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation.

Miranda S M Tsang, Delong Jiao, Ben C L Chan, Kam-Lun Hon, Ping C Leung, Clara B S Lau, Eric C W Wong, Ling Cheng, Carmen K M Chan, Christopher W K Lam and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The Anaphylactic and Anti-allergenic Properties of Shuanghuanglian: A Review.Combinatorial chemistry & high throughput screening · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. International journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Molecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Miranda S M TsangInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. tsangsinman0128@gmail.com.
Delong JiaoDepartment of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China. j.dl@foxmail.com.
Ben C L ChanInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. benchan99@cuhk.edu.hk.
Kam-Lun HonInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. ehon@cuhk.edu.hk.
Ping C LeungInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. pingcleung@cuhk.edu.hk.
Clara B S LauInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. claralau@cuhk.edu.hk.
Eric C W WongInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. cwwong_eric@cuhk.edu.hk.
Ling ChengInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. b750741@mailserv.cuhk.edu.hk.
Carmen K M ChanInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. ckmchan@cuhk.edu.hk.
Christopher W K LamState Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China. wklam@must.edu.mo.
Chun K WongInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk.
Chinese University of Hong Kong · HKMacau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a common allergic skin disease, characterized by dryness, itchiness, thickening and inflammation of the skin. Infiltration of eosinophils into the dermal layer and presence of edema are typical characteristics in the skin biopsy of AD patients. Previous in vitro and clinical studies showed that the Pentaherbs formula (PHF) consisting of five traditional Chinese herbal medicines, Flos Lonicerae, Herba Menthae, Cortex Phellodendri, Cortex Moutan and Rhizoma Atractylodis at w/w ratio of 2:1:2:2:2 exhibited therapeutic potential in treating AD. In this study, an in vivo murine model with oxazolone (OXA)-mediated dermatitis was used to elucidate the efficacy of PHF. Active ingredients of PHF water extract were also identified and quantified, and their in vitro anti-inflammatory activities on pruritogenic cytokine IL-31- and alarmin IL-33-activated human eosinophils and dermal fibroblasts were evaluated. Ear swelling, epidermis thickening and eosinophils infiltration in epidermal and dermal layers, and the release of serum IL-12 of the murine OXA-mediated dermatitis were significantly reduced upon oral or topical treatment with PHF (all p < 0.05). Gallic acid, chlorogenic acid and berberine contents (w/w) in PHF were found to be 0.479%, 1.201% and 0.022%, respectively. Gallic acid and chlorogenic acid could suppress the release of pro-inflammatory cytokine IL-6 and chemokine CCL7 and CXCL8, respectively, in IL-31- and IL-33-treated eosinophils-dermal fibroblasts co-culture; while berberine could suppress the release of IL-6, CXCL8, CCL2 and CCL7 in the eosinophil culture and eosinophils-dermal fibroblasts co-culture (all p < 0.05). These findings suggest that PHF can ameliorate allergic inflammation and attenuate the activation of eosinophils.

Indexed as

AnimalsAnti-Inflammatory AgentsBerberineCells, CulturedChemokinesChlorogenic AcidCoculture TechniquesDermatitis, AtopicDisease Models, AnimalDrugs, Chinese HerbalEosinophilsFibroblastsGallic AcidHumansInterleukin-12Medicine, Chinese TraditionalAnti-Inflammatory AgentsBerberineChemokinesChlorogenic AcidDrugs, Chinese HerbalGallic AcidInterleukin-12Oxazoloneallergic inflammationatopic dermatitisberberineGallic acidpentaherbs formula

Identifiers

PMID27104513
PMCPMC6274171
OpenAlexW2338183893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.